Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

624 Articles

Chris Lange | May 19, 2018 at 8:25 AM EDT

9 Companies Bracing for Big ASCO Reactions

This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.

Trey Thoelcke | May 18, 2018 at 8:00 AM EDT

Amgen’s Novel Migraine Treatment Gets Key Approval

Amgen shares saw a nice bump after the FDA on Thursday approved its preventive treatment of migraine in adults.

Chris Lange | May 10, 2018 at 10:20 AM EDT

Short Sellers Run for Cover From Major Pharma

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 24, 2018 at 12:20 PM EDT

Why Eli Lilly’s Big Earnings Beat, Rosy Guidance Were Not Enough

Eli Lilly released its most recent quarterly earnings report before the markets opened on Tuesday.

Chris Lange | Apr 22, 2018 at 10:15 AM EDT

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and…

Chris Lange | Apr 20, 2018 at 10:35 AM EDT

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Incyte and Eli Lilly will be under the microscope next week as the FDA will decide the fate of their…

Jon C. Ogg | Apr 13, 2018 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: BBVA, Bed Bath & Beyond, Dropbox, Eli Lilly, Netflix, P&G, Splunk, Starbucks and More

The top analyst upgrades, downgrades and other research calls from Friday include BBVA, Bed Bath & Beyond, Dropbox, Eli Lilly,…

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Mar 12, 2018 at 8:35 AM EDT

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 28, 2018 at 9:10 AM EST

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Feb 12, 2018 at 9:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Feb 8, 2018 at 8:15 AM EST

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety…

Chris Lange | Jan 31, 2018 at 8:50 AM EST

Eli Lilly Cruises Through Q4 Earnings

Eli Lilly reported better-than-expected fourth-quarter financial results before the markets opened on Wednesday.

1 … 19 20 21 22 23 … 42

Eli Lilly : LLY

All Eli Lilly Articles

9 Companies Bracing for Big ASCO Reactions

Amgen’s Novel Migraine Treatment Gets Key Approval

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma Stocks

Why Eli Lilly’s Big Earnings Beat, Rosy Guidance Were Not Enough

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Top Analyst Upgrades and Downgrades: BBVA, Bed Bath & Beyond, Dropbox, Eli Lilly, Netflix, P&G, Splunk, Starbucks and More

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Eli Lilly Cruises Through Q4 Earnings

Fastenal (FAST): The Quiet Compounder Nobody Talks About Is a Buy-and-Hold-Forever Stock

Beyond SpaceX — Firefly Is the Space Stock You Can Actually Buy Today

2 Top AI Stocks To Put On Your Shortlist

Here Is What I Would Tell a Tech Founder Heading Into a Tax-Free Decade of Early Retirement

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?

Fastenal (FAST): The Quiet Compounder Nobody Talks About Is a Buy-and-Hold-Forever Stock

Beyond SpaceX — Firefly Is the Space Stock You Can Actually Buy Today

Eli Lilly : LLY

All Eli Lilly Articles

9 Companies Bracing for Big ASCO Reactions

Amgen’s Novel Migraine Treatment Gets Key Approval

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma Stocks

Why Eli Lilly’s Big Earnings Beat, Rosy Guidance Were Not Enough

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Top Analyst Upgrades and Downgrades: BBVA, Bed Bath & Beyond, Dropbox, Eli Lilly, Netflix, P&G, Splunk, Starbucks and More

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Eli Lilly Cruises Through Q4 Earnings

Fastenal (FAST): The Quiet Compounder Nobody Talks About Is a Buy-and-Hold-Forever Stock

Beyond SpaceX — Firefly Is the Space Stock You Can Actually Buy Today

2 Top AI Stocks To Put On Your Shortlist

Featured Reads

Here Is What I Would Tell a Tech Founder Heading Into a Tax-Free Decade of Early Retirement

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?